Pregnancy and Ehlers-Danlos Syndrome (EDS)

Pregnancy and Ehlers-Danlos syndrome — scientific infographic poster

Overview — What Pregnancy Looks Like with Ehlers-Danlos Syndrome
Hypermobile Ehlers-Danlos Syndrome (hEDS) in Pregnancy
Symphysis Pubis Dysfunction and Pelvic Girdle Pain
Cervical Insufficiency — The Underappreciated Risk
Classical Ehlers-Danlos Syndrome (cEDS) in Pregnancy
Vascular Ehlers-Danlos Syndrome (vEDS) — The High-Stakes Subtype
Postural Orthostatic Tachycardia Syndrome in Pregnancy
Mast Cell Activation Syndrome Medications in Pregnancy
Anesthesia Considerations
Labor, Delivery & Cesarean Risks
Postpartum Recovery — Pelvic Floor, Mood, Flares
Breastfeeding with Ehlers-Danlos Syndrome
Fertility, IVF & Family Planning
Who Needs a High-Risk Maternal-Fetal Medicine (MFM) Obstetrician
Key Research Papers
Connections
Featured Videos

Overview — What Pregnancy Looks Like with Ehlers-Danlos Syndrome

Pregnancy with Ehlers-Danlos Syndrome is usually possible, frequently uncomfortable, and — in one specific subtype — genuinely dangerous. Most women with hypermobile Ehlers-Danlos syndrome (hEDS) carry successful pregnancies, deliver healthy babies, and recover, though the process typically amplifies every connective-tissue complaint they had before conceiving. Women with classical Ehlers-Danlos syndrome (cEDS) face similar issues plus a meaningful risk of premature rupture of membranes. Women with vascular Ehlers-Danlos syndrome (vEDS) face a real risk of death in pregnancy — a 2014 study of vEDS family trees counted 30 pregnancy-related deaths in 565 deliveries (5.3%) — and every pregnancy decision is individualized with a specialized team.

The dominant theme across all subtypes is the effect of relaxin — the hormone that softens connective tissue to allow the pelvis to open during delivery. In someone whose collagen is already loose, relaxin is a double dose of instability. Joints that were already subluxating pre-pregnancy now subluxate more often. Ligaments that were already stretchy now stretch to the point of injury. Skin that was already fragile now splits into striae at a rate that shocks first-time mothers. None of this is in your head, and none of it means you did something wrong.

The good news: knowledge matters. Women who enter pregnancy with a diagnosis, a specialist team, and a written plan do measurably better than those who are figuring it out as they go. This article walks through what to expect, what to screen for, and what to ask for.

Hypermobile Ehlers-Danlos Syndrome (hEDS) in Pregnancy

The majority of Ehlers-Danlos syndrome pregnancies are hEDS pregnancies, because hEDS is by far the most common subtype. The overall obstetric outcome is generally good, but specific complications are common enough that they should be anticipated, not improvised around.

Joint instability. Relaxin levels rise early in the first trimester, peak around week 14, and remain elevated until delivery. On top of already lax ligaments, the result is predictable: more frequent subluxations of the hips, knees, shoulders, and sacroiliac (SI) joints; increased clumsiness and falls; and new instability in joints that had previously been stable. Bracing, careful transfer mechanics, and pregnancy-specific physical therapy help. Deep squats, asymmetric weight-bearing, and carrying a toddler on one hip all put extra load on loosened joints.

Striae and skin stretching. The combination of naturally elastic skin and rapid abdominal expansion produces striae gravidarum earlier, more extensively, and in more unusual distributions (flanks, breasts, thighs) than in the general obstetric population. Topicals do not prevent them. This is cosmetic, not dangerous.

Carpal tunnel and other compression neuropathies. Pregnancy-associated fluid shifts cause carpal tunnel in roughly a quarter of all pregnancies; the rate in hEDS is higher because the flexor retinaculum is already lax and peripheral nerves are more prone to mechanical injury. Night splints help. Most cases resolve by six to twelve weeks postpartum.

Rapid or precipitous labor. hEDS labor tends to be faster than average. Some women deliver within two to three hours of the first contraction, sometimes before reaching the hospital. A plan for early arrival and local paramedic awareness of the possibility is reasonable for anyone with a prior precipitous labor or a long commute to the hospital.

Postpartum hemorrhage. Connective-tissue fragility of the uterus and vaginal tissues increases the risk of heavier-than-average postpartum bleeding. Active management of the third stage (oxytocin, controlled cord traction) is the standard practice.

What one study measured. A 2012 Italian study of 82 women with the hypermobile type recorded 93 pregnancies: 16.1% ended in miscarriage and 10.7% in preterm birth, and there were no stillbirths. Births were vaginal without instruments in 72.2%, with forceps or vacuum in 5.5%, and by cesarean in 22.3%. After birth, abnormal scarring after a cesarean or episiotomy occurred in 46.1%, heavy bleeding (hemorrhage) in 19.4%, and pelvic prolapse in 15.3%; prolapse was the most important complication and was linked to episiotomy.

Symphysis Pubis Dysfunction and Pelvic Girdle Pain

Symphysis pubis dysfunction (SPD) — sometimes called pregnancy-related pelvic girdle pain — occurs in perhaps one in five unselected pregnancies. In hEDS it is more common, more severe, and lasts longer postpartum. The symphysis pubis, the SI joints, and the surrounding ligaments soften under relaxin; in Ehlers-Danlos syndrome they soften further, and the resulting separation can be painful enough to make walking, stair-climbing, rolling over in bed, and putting on pants genuinely difficult.

Practical management:

Pelvic support belt worn daily from the second trimester onward. Multiple brands exist; fit matters more than brand.
Keep knees together for all transitional movements — getting in and out of the car, rolling over, getting up from a chair. Asymmetric leg movement widens the symphysis painfully.
Crutches or a walker are not overkill in severe cases. They preserve mobility and reduce SI strain.
Pelvic-floor-informed physical therapy with a therapist experienced in hypermobility. Generic "prenatal yoga" can worsen things by stretching already lax structures.
Side-lying with a pillow between the knees is the least painful sleep position.

SPD often lingers six to twelve months postpartum in hEDS, and occasionally longer. It should not be dismissed as "just pregnancy pain."

Cervical Insufficiency — The Underappreciated Risk

Cervical insufficiency — the cervix opening silently and prematurely — is under-recognized in Ehlers-Danlos syndrome. The cervix is a connective-tissue structure. In women with collagen disorders, it is mechanically weaker than in the general population, and preterm dilation without contractions is a documented risk.

A reasonable screening protocol for any Ehlers-Danlos syndrome pregnancy:

Transvaginal cervical length measurement every two to four weeks from 16 to 24 weeks. This is the window in which cervical shortening typically appears.
Cerclage (a surgical stitch to reinforce the cervix) if the cervix shortens below 25 mm or if there is a history of preterm delivery or prior second-trimester loss. Cerclage in Ehlers-Danlos syndrome is technically more challenging because the tissue holds sutures less reliably; some surgeons place reinforcing sutures.
Vaginal progesterone may be added for short-cervix findings.

Standard-risk pregnancies do not get routine cervical length surveillance, and many obstetricians unfamiliar with Ehlers-Danlos syndrome add it only when the patient asks for it.

Classical Ehlers-Danlos Syndrome (cEDS) in Pregnancy

cEDS — caused by mutations in COL5A1 or COL5A2 — shares the hEDS concerns listed above and adds its own. The central issue is amniotic sac fragility. Some case series report premature rupture of membranes (PROM) in up to 50% of cEDS pregnancies, sometimes weeks before the due date. This can precipitate preterm delivery.

Additional cEDS concerns:

Skin wound healing is slower. If a cesarean is required, sutures are typically left in longer (often double the standard duration), and some surgeons use retention sutures or a layered closure to compensate for tissue that holds stitches poorly.
Vaginal tears and episiotomy wounds heal slowly and dehisce more often. Some obstetricians favor elective episiotomy in cEDS to make a clean controllable incision rather than risk an irregular tear; others argue the opposite. Discuss ahead of time.
Uterine prolapse risk after parity is higher than in the general population, particularly after multiple deliveries.
Neonatal screening — the baby may have inherited cEDS. Careful handling at delivery (to avoid clavicle fracture, cephalohematoma) is reasonable, and pediatric follow-up for hypermobility features is usually arranged.

Vascular Ehlers-Danlos Syndrome (vEDS) — The High-Stakes Subtype

vEDS is different. It is caused by mutations in COL3A1, the gene for type III collagen, which is the scaffold of arteries, the uterus, and hollow organs. Pregnancy in vEDS is a genuine, life-threatening undertaking. A 2014 study of vEDS family trees counted pregnancy-related deaths in 30 of 565 deliveries (5.3%), and interviews covering 76 deliveries found 5 maternal deaths (6.5%); the dangers are tearing or rupture of arteries and rupture of the uterus during labor and the early postpartum period.

The same study found that 46% of the interviewed deliveries were uncomplicated. Life-threatening complications occurred in 14.5% of deliveries: arterial dissection or rupture in 9.2%, uterine rupture in 2.6%, and surgical complications in 2.6%. Women with vEDS who had given birth did not have shorter survival than women with vEDS who had not. A 2026 systematic review found published vEDS maternal death rates ranging from 0.10% to 50%; its authors attribute the wide range to older studies done before modern genetic testing. Across the studies it included, preterm birth was the most common complication (8.9% to 48.8% of pregnancies), and early rupture of the membranes was strongly tied to the baby having Ehlers-Danlos syndrome.

No part of this article is a reason to panic if you already have vEDS and are pregnant. Modern specialized care — early diagnosis, preconception vascular imaging, celiprolol, planned delivery at a tertiary center with cardiothoracic surgery on site, and elective cesarean timing — has improved outcomes significantly in reported cohorts. But the decision to pursue pregnancy in vEDS is a decision that deserves a detailed individualized counseling session, ideally with a geneticist, a maternal-fetal medicine specialist, and a vascular surgeon at a center that sees vEDS regularly.

Key points that come up repeatedly in vEDS pregnancy counseling:

Preconception whole-body MRA (magnetic resonance angiography) to map aneurysms, dissections, and baseline arterial anatomy.
Celiprolol is often continued in pregnancy when it is tolerated and the prescriber judges that the benefit outweighs the fetal risk. In the BBEST trial (2010), an open randomized trial with blinded assessment of events, arterial events occurred in 20% of patients on celiprolol and 50% of untreated controls. A 2025 randomized placebo-controlled trial in 57 adults already taking celiprolol found that adding irbesartan (an angiotensin II receptor blocker) lowered arterial events or new or worsening arterial lesions over 2 years to 27.6%, against 53.6% on placebo. The U.S. irbesartan label carries a boxed warning on fetal toxicity: the drug is to be stopped as soon as possible when pregnancy is detected, because drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
Delivery at a center with 24/7 cardiothoracic surgery capable of emergency aortic repair is the standard plan.
Some experts recommend elective cesarean at 34–36 weeks under controlled conditions to avoid the hemodynamic stress and uterine contractility of full-term labor. Others individualize based on imaging and prior history. The 2014 study of pregnancy deaths found the data insufficient to tell whether the mode or timing of delivery changed the risk of complications, and its authors describe a shared decision-making process. There is no single accepted protocol — the point is that the decision is made deliberately, not in an emergency.
The early postpartum period (the first two weeks) carries ongoing risk of vascular events and requires close monitoring.
Family planning options for women with known COL3A1 mutations who want biological children but want to avoid or reduce pregnancy risk: preimplantation genetic diagnosis (PGD) with in vitro fertilisation (IVF) to select unaffected embryos, gestational surrogacy, donor egg with a non-vEDS surrogate, or adoption. All four are medically reasonable. This is a values discussion, not just a medical one.

Postural Orthostatic Tachycardia Syndrome in Pregnancy

Postural orthostatic tachycardia syndrome is common in hEDS (see postural orthostatic tachycardia syndrome (POTS)), and its behavior in pregnancy is counterintuitive.

First trimester: usually worse. Blood volume has not yet expanded but vasodilation has, so standing tachycardia and presyncope intensify. Morning sickness and reduced fluid/salt intake make it worse.
Second trimester: often better. Plasma volume has expanded by 30–50%, which happens to be the exact intervention postural orthostatic tachycardia syndrome patients chase with intravenous (IV) fluids. Many women feel the best they have felt in years during the second trimester.
Third trimester: mixed. Volume is still high, but mechanical compression of the inferior vena cava by the uterus can provoke supine symptoms and syncope.
Postpartum: often rebounds harder than pre-pregnancy. Volume drops back over weeks, diuresis is rapid, and sleep deprivation is severe. Many women describe a rough 6–12 weeks postpartum, and salt, fluids, and compression are often resumed immediately after delivery.

Medication during pregnancy is individualized. Beta-blockers (metoprolol, propranolol) are widely used in pregnancy with a long safety record. Midodrine has less pregnancy data. (The old FDA letter categories such as “category C” were removed from prescription drug labels by the FDA’s 2015 Pregnancy and Lactation Labeling Rule; current labels describe the available data in a Pregnancy subsection, 8.1.) Fludrocortisone is used in some pregnancies when volume expansion is inadequate. Ivabradine data in pregnancy are too limited for routine use. Non-pharmacologic measures — compression stockings (preferably abdominal compression too), 3–5 grams/day of sodium, 2.5–3 liters of fluid, and left-lateral sleeping — are usually maximized first.

Mast Cell Activation Syndrome Medications in Pregnancy

Mast cell activation syndrome (see mast cell activation syndrome (MCAS)) commonly travels with Ehlers-Danlos syndrome. Pregnancy itself can either quiet or inflame mast cells, and it is not predictable which way a given woman will go. A baseline regimen that works is generally continued, with a few medication-specific notes:

H1 antihistamines, second generation: cetirizine, loratadine, and levocetirizine have reassuring pregnancy safety data and are the usual workhorses.
H1 first generation: diphenhydramine and hydroxyzine are used in pregnancy but more sedating; hydroxyzine is typically avoided in the first trimester.
H2 antihistamines: famotidine is the default; ranitidine was withdrawn in 2020 for contamination with N-nitrosodimethylamine (NDMA) and is no longer available.
Cromolyn sodium (oral): poorly absorbed, broadly considered safe in pregnancy, useful for gastrointestinal (GI) mast cell symptoms.
Ketotifen: not available in the United States, though used abroad.
Montelukast: used when needed; data are reassuring overall.
Aspirin, low-dose: used selectively for prostaglandin-mediated symptoms and also, independently, for preeclampsia prevention in high-risk patients.

The general principle clinicians describe is not introducing new mast-cell triggers in pregnancy, such as a novel food, supplement, or medication that is not clearly necessary. Abruptly stopping a working regimen carries its own risk — a severe mast-cell reaction mid-pregnancy is worse for the fetus than continuing well-tolerated antihistamines.

Anesthesia Considerations

Anesthesia in Ehlers-Danlos syndrome deserves its own conversation before labor begins. The issues are real, well-documented, and routinely under-anticipated by general obstetric anesthesia teams.

Resistance to local anesthetics. A well-described phenomenon in Ehlers-Danlos syndrome — injected lidocaine, bupivacaine, and similar agents wear off faster than expected or fail to fully anesthetize. Some patients bring an Ehlers-Danlos syndrome anesthesia information card to the delivery hospital so the anesthesiologist can review it in advance, and block effectiveness is double-checked before the procedure starts. The resistance is not universal: in a 2012 Italian study of women with the hypermobile type, local or general anesthesia was used in 17 pregnancies without any problem.
Difficult epidural placement. Atypical spinal anatomy, ligamentum flavum laxity, and the loss of the classic "loss of resistance" endpoint make epidural placement technically harder. A senior anesthesiologist, not a trainee, is a reasonable request.
Extended duration of block required. Catheter placement is often planned early if labor is progressing slowly, rather than left until transition.
Dural puncture and post-dural-puncture headache. Connective-tissue fragility increases the chance of inadvertent dural puncture and may prolong the resulting cerebrospinal fluid (CSF) leak headache. Epidural blood patches work but may need to be repeated.
Cervical spine caution. If general anesthesia is required, cervical instability may complicate intubation, which is why the anesthesia team is told about it in advance.

Many women write the anesthesia plan into the birth plan, share it with the obstetrician in advance, and have an antepartum anesthesia consultation — typically at 32–36 weeks — so the team meets them before active labor.

Labor, Delivery & Cesarean Risks

Vaginal delivery is possible and often preferred in hEDS. Cesarean is sometimes chosen electively (maternal request, prior severe SPD, fetal or positional indications, vEDS) and sometimes required for obstetric reasons. Both routes carry Ehlers-Danlos syndrome-specific risks.

Vaginal delivery concerns: precipitous labor, perineal tears (possibly extending further than expected through fragile tissue), episiotomy that heals slowly, and postpartum hemorrhage from uterine or vaginal tissue fragility.

Cesarean concerns: intraoperative tissue friability (fascia, uterus, and skin all hold sutures less reliably), slow wound healing, higher rates of wound dehiscence, higher rates of incisional hernia, and in vEDS the risk of arterial injury during surgery. Cesarean in Ehlers-Danlos syndrome typically involves longer suture duration, slower activity progression postpartum, and a longer hospital stay for monitoring.

Either way, recovery is usually longer than for an average-risk mother. Three to six weeks of explicit lifting restrictions is reasonable, and "getting back to normal" at six weeks is an unrealistic expectation that many women blame themselves for. Three months is a more realistic span.

Postpartum Recovery — Pelvic Floor, Mood, Flares

Postpartum is frequently the hardest phase of an Ehlers-Danlos syndrome pregnancy. Three problems cluster here:

Joint flare. Relaxin lingers for several months, particularly while breastfeeding. Joints that were hanging on during pregnancy often destabilize in the first six to twelve weeks postpartum, with a wave of subluxations, pain, and functional loss. Many women line up braces, physical therapy (PT) appointments, and help with the baby before delivery.

Pelvic floor dysfunction. Urinary incontinence, fecal incontinence, and early pelvic organ prolapse are all more common after delivery in Ehlers-Danlos syndrome. An early (6–8 week) pelvic-floor PT evaluation — not a generic one, but with someone who works with hypermobility — is one of the highest-yield interventions for long-term quality of life. Long-term pelvic organ prolapse risk after parity is elevated in Ehlers-Danlos syndrome, with symptoms sometimes appearing years after delivery.

Postpartum mood. Postpartum depression and anxiety rates are higher in Ehlers-Danlos syndrome. The drivers are obvious in retrospect: severe sleep deprivation in someone who already slept poorly, hormonal collapse, joint flare, pain, and a body that does not feel like it is recovering. This is a medical problem, not a character flaw. Selective serotonin reuptake inhibitors (SSRIs), therapy, sleep support, and a low threshold for formal postpartum mental health care are all options.

Breastfeeding with Ehlers-Danlos Syndrome

Breastfeeding is usually possible in Ehlers-Danlos syndrome, but positioning is the deal-breaker. Holding a newborn in a cradle position for 30–45 minutes, eight to twelve times a day, routinely subluxates shoulders, strains wrists, and aggravates neck pain in hEDS. Solutions:

Side-lying nursing for the first weeks — far less load on shoulders and wrists.
Nursing pillows to take the weight off the arms.
Football hold after cesarean to keep pressure off the incision.
Pumping as a full or partial substitute if latch-related strain becomes unsustainable.
Medication compatibility: the U.S. National Institutes of Health (NIH) LactMed database covers Ehlers-Danlos syndrome-related medications (beta-blockers, antihistamines, nonsteroidal anti-inflammatory drugs (NSAIDs), selective serotonin reuptake inhibitors). Most commonly used agents have reassuring data.

Positions that injure the mother's joints are not a requirement of breastfeeding, whatever an aggressive lactation consultant suggests. Fed is not just a slogan — for a recovering Ehlers-Danlos syndrome mother, sustainable is the whole game.

Fertility, IVF & Family Planning

Baseline fertility in hEDS is generally normal. cEDS and vEDS fertility rates do not appear substantially reduced either, though the decision to attempt pregnancy in vEDS is dominated by risk, not fertility. Ehlers-Danlos syndrome overlaps heavily with endometriosis, which can reduce fertility and cause significant cyclical pain; women in this overlap population sometimes need assisted reproduction (see Infertility).

If IVF is pursued:

Oocyte retrieval requires extra care — the vaginal wall and ovarian tissue are more fragile, and bleeding from retrieval puncture sites is more common. Communicate the diagnosis clearly to the reproductive endocrinologist.
Ovarian hyperstimulation syndrome (OHSS) is treated the same way as in non-EDS patients, but fluid shifts can destabilize coexisting postural orthostatic tachycardia syndrome.
Preimplantation genetic diagnosis (PGD) is available for families with a known COL3A1 (vEDS) mutation, and increasingly for families with known COL5A1/COL5A2 (cEDS) mutations. hEDS does not yet have a reliable genetic marker, so PGD is not available for hEDS.

Who Needs a High-Risk Maternal-Fetal Medicine (MFM) Obstetrician

Not every Ehlers-Danlos syndrome pregnancy needs maternal-fetal medicine, but many have at least a consultation. A practical cutoff:

Vascular Ehlers-Danlos syndrome — always. Full MFM co-management, delivery at a tertiary center with cardiothoracic surgery, individualized delivery plan.
Classical Ehlers-Danlos syndrome — usually. PROM risk, cervical-length surveillance, and delivery planning justify MFM involvement.
Hypermobile Ehlers-Danlos syndrome — selectively. MFM referral is usual when any of the following apply: prior preterm delivery, prior second-trimester loss, severe postural orthostatic tachycardia syndrome or mast cell activation syndrome, cervical shortening on surveillance, prior precipitous labor with complications, prior postpartum hemorrhage, or severe joint instability requiring specific delivery planning.
Any subtype + significant comorbidity — thyroid disease (see Pregnancy and Hashimoto's), cardiac disease, prior preeclampsia (see Preeclampsia) — is worth at least one MFM visit.

The goal is not to medicalize a pregnancy that does not need it. The goal is to make sure the team knows what Ehlers-Danlos syndrome is before a complication arrives, not after.

Key Research Papers

Pepin MG, Schwarze U, Rice KM, Liu M, Leistritz D, Byers PH. Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV). Genet Med. 2014;16(12):881-8. — PubMed PMID: 24922459
Murray ML, Pepin M, Peterson S, Byers PH. Pregnancy-related deaths and complications in women with vascular Ehlers-Danlos syndrome. Genet Med. 2014;16(12):874-80. — PubMed PMID: 24922461
Castori M, Morlino S, Dordoni C, Celletti C, Camerota F, Ritelli M, Morrone A, Venturini M, Grammatico P, Colombi M. Gynecologic and obstetric implications of the joint hypermobility syndrome (a.k.a. Ehlers-Danlos syndrome hypermobility type) in 82 Italian patients. Am J Med Genet A. 2012;158A(9):2176-82. — PubMed PMID: 22847925
Almheiri S, ElMubarak A, Fadlalsaed O. Pregnancy Outcomes in Women With Vascular Ehlers-Danlos Syndrome: A Systematic Review of Maternal and Fetal Complications. Cureus. 2026;18(8):e114336. — PubMed PMID: 42725136
Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010;376(9751):1476-84. — PubMed PMID: 20825986
Jeunemaitre X, Mousseaux E, Frank M, et al. Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos Syndrome. Circulation. 2025;151(10):686-695. — PubMed PMID: 39906986
U.S. National Library of Medicine. DailyMed: irbesartan tablets prescribing information, boxed warning “Fetal Toxicity”. — DailyMed irbesartan label
U.S. Food and Drug Administration. Pregnancy and Lactation Labeling (Drugs) Final Rule. — FDA: Pregnancy and Lactation Labeling Rule

PubMed Topic Searches

The following PubMed topic searches return current peer-reviewed work on Ehlers-Danlos syndrome in pregnancy:

Back to Table of Contents